Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOM · Entity 6884 | Chief Commercial Officer | December 31, 2020 | January 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date December 31, 2020 · Filed January 05, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.23 · Expires 2030-12-30 | Direct | 3,000,000 |
Reported balance
After 2020-12-31 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2020-12-31 · Grant · Acquired 3,000,000 · Balance 3,000,000 F1: The option vests in 4 equal annual installments commencing December 30, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in 4 equal annual installments commencing December 30, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 5, 2021 16:08 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 3,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000080 · ownership.xml · derivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Shares, without par value · 3,000,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 30, 2021. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 16:09 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 3,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000026 · ownership.xml · derivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Shares, without par value · 3,000,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 30, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 16:11 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 700,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001786 · ownership.xml · derivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Shares, without par value · 700,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 16:08 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000259 · ownership.xml · derivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Shares, without par value · 300,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 16:04 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 62,996 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000353 · zomedica_form4mar292018.xml · derivative · entry 5 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,004 Underlying: Common Shares, without par value · 62,996 shares Expires 2019-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 16:04 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 62,996 | $2.20 | $138,591.20 |
DisclosureSEC source: 0000905718-18-000353 · zomedica_form4mar292018.xml · nonDerivative · entry 1 Herbst Bruk · CIK 0001721753 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.